Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Cantab completes acquisition of drug addiction programs from ImmuLogic

Feb. 3, 1999

Studies in knockout mice support the role of CB1 receptor in opiate addiction

Jan. 26, 1999

Potent and selective DAT ligand identified by RTI and Emory University

Jan. 22, 1999

Novel pure mu/kappa-opioid receptor antagonist as a lead in the field of drug abuse therapy

Jan. 20, 1999

Orphan drug for iron overload offered for licensing by Biomedical Frontiers

Jan. 18, 1999

Generic smoking cessation aid receives tentative FDA approval

Jan. 13, 1999

Novel cocaine analogues with promise in the treatment of cocaine addiction or overdose

Jan. 8, 1999

FDA approves OTC status for Elan's nicotine patch

Jan. 7, 1999

Selective inhibitor of neuronal dopamine transporter developed by U.S. university team

Jan. 4, 1999

Lilly develops novel 5-HT1A/5-HT1D antagonists for smoking cessation and CNS disorders

Dec. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 27, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...